Authors

• Daniel Heudobler (ORCID: https://orcid.org/0000-0002-8790-4584)
• Carlos Gomez‐Roca (ORCID: https://orcid.org/0000-0002-8043-2529)
• Ronnie Shapira-Frommer
• Chinyere E. Okpara (ORCID: https://orcid.org/0000-0002-5621-9138)
• Sanjeev Gill
• A. Santoro
• Roman Groisberg (ORCID: https://orcid.org/0000-0001-8970-7675)
• Razi Ghori (ORCID: https://orcid.org/0009-0004-3095-8612)
• Ravit Geva
• Corina E. Dutcus (ORCID: https://orcid.org/0000-0003-3483-716X)
• Amir Vajdi (ORCID: https://orcid.org/0000-0001-8271-8566)
• Yiwei Zhang (ORCID: https://orcid.org/0000-0003-1751-6006)
• Feng Jin (ORCID: https://orcid.org/0000-0002-4450-6084)
• Giampaolo Tortora
• EJ Dettman
• Mariano Ponz-Sarvise
• Tae Won. Kim
• Laura Ortega Morán
• Esma Saada-Bouzid

Institutions

• Università Cattolica del Sacro Cuore (IT)
• Humanitas University (IT)
• Yonsei University (KR)
• Tel Aviv Sourasky Medical Center (IL)
• Sheba Medical Center (IL)
• Asan Medical Center (KR)
• The Alfred Hospital (AU)
• Agostino Gemelli University Polyclinic (IT)
• Hospital General Universitario Gregorio Marañón (ES)
• University Hospital Regensburg (DE)
• University of Ulsan (KR)
• Institut universitaire du cancer de Toulouse Oncopole (FR)
• Merck Institute for Science Education (US)
• Nutrasource (CA)
• Clinica Universidad de Navarra (ES)
• Cognition Behaviour Technology (FR)
• Eisai (United Kingdom) (GB)
• Centre Antoine Lacassagne (FR)
• IRCCS Humanitas Research Hospital (IT)
• Universidad de Navarra (ES)

Publication Details

Journal

Cancer Research Communications

Published

2026-02-26

DOI

https://doi.org/10.1158/2767-9764.crc-26-0018

Primary Topic

Cholangiocarcinoma and Gallbladder Cancer Studies

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Eisai